The weight-loss drugs are linked with reduced rates of excess drinking and opioid overdoses, suggesting they may tamp down substance use cravings too.
Ozempic
Posted inNPR
Weight-loss drugs like Wegovy may help stave off some cancers
Several new studies find promising evidence that the GLP-1 class of drugs may have a cancer-preventive effect, especially for cancers linked to obesity.
Posted inNPR
Ozempic’s popularity leads to shortages for people with Type 2 diabetes
Drugs like Ozempic, Wegovy and Mounjaro are in such high demand that many patients with Type 2 diabetes can’t get them when they need them.
Posted inNPR
Have the new weight-loss drugs changed what it means to be body positive?
America is a land of contradictions; while we’re known as a nation that loves to eat, we also live within a culture that has long valued thinness as the utmost beauty standard.
Over the last several years the body positivity movement has pushed back on that notion. But then came a new class of weight-loss drugs.
New York Magazine contributing writer Samhita Mukhopadhyay grapples with the possible future of a movement like this in her recent article, So Was Body Positivity All A Big Lie?
She joins All Things Considered host Juana Summers to discuss the ever-evolving conversation on health, size, and whose business that is in the first place.
For sponsor-free episodes of Consider This, sign up for Consider This+ via Apple Podcasts or at plus.npr.org.
Email us at considerthis@npr.org.
